Intelligence / Logistics & supply chain market map / Cold-chain infrastructure and monitoring equipment / Cold-store systems and temperature-controlled storage equipment / Pharma manufacturers outsourcing temperature-controlled storage
Pharma manufacturers outsourcing temperature-controlled storage
Pharmaceutical manufacturers and biologic, vaccine, gene-therapy and cell-therapy producers that need outsourced cold-store capacity, validated storage modules and monitored handling of temperature-sensitive products between manufacturing and patient delivery. Buyer job: maintain validated temperature control and documented chain-of-custody evidence under FDA 21 CFR Part 211, EU GMP Annex 15 and WHO GDP guidance. Trigger: growth in temperature-sensitive pharmaceutical volumes, new biologics or cell-therapy launches, and regulatory requirements for documented temperature maintenance. Distinct from cold-chain monitoring buyers because this niche is defined by outsourced storage capacity and va
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Pharmaceutical manufacturers and CDMOs
- Buying centre
- Quality assurance and regulatory affairs lead the specification and approval; supply chain and manufacturing operations own the budget; procurement runs sourcing; logistics and cold-storage operators can be contracted capacity suppliers. Decision criteria include validated temperature zones, calibra
- Expansion of temperature-sensitive pharmaceutical volumes, including biologics, vaccines, gene therapies and cell therapies
- Entry of new biologics, vaccines or cell-therapy products requiring validated storage
- Regulatory frameworks requiring documented evidence of maintained cold-chain conditions
- Requirement for contingency capacity during supply disruptions or facility transitions
- Risk of temperature excursions invalidating batches or clinical supply
- Gaps in documented chain-of-custody evidence
- Limited surge or backup capacity for launches and supply disruptions
- Fragmented monitoring and record systems across storage, transport and quality workflows
How this was sized
Not sized yet
No source provides the supplier revenue attributable specifically to pharmaceutical cold-store systems. Proxy inputs: global cold-chain monitoring market was USD 9.07bn in 2025 [5], and monitoring is an adjacent segment rather than a direct measure of storage-system revenue. A defensible niche split cannot be derived without storage-capacity or end-use revenue shares, so no niche revenue is stated. Confidence in the absence of a published allocation is Low.
- Global Cold Chain Monitoring Market Size, Share & Trends | Industry Report 2035
emergenresearch.com · 2026-07-02 - Cold Chain Monitoring Market Size, Share, Growth, Analysis, 2034
straitsresearch.com
Alongside it in Cold-store systems and temperature-controlled storage equipment
// Sell into Pharma manufacturers outsourcing temperature-controlled storage